TITLE:
Clinical and Magnetic Resonance Imaging Outcomes of Arthroscopic Intratendinous Human-Derived Collagen Injection for Partial-Thickness Rotator Cuff Tears: A Retrospective Comparative Study
AUTHORS:
Dong Nyoung Lee, Chang Hyun Nam, Jung Hoon Lee, Ji-Hoon Baek, Soon Yong Yoo, Kyungwon Choi, Hye Sun Ahn, Su Chan Lee
KEYWORDS:
Partial-Thickness Rotator Cuff Tear, Human-Derived Collagen, Intratendinous Injection, Acromioplasty, Magnetic Resonance Imaging
JOURNAL NAME:
Open Journal of Orthopedics,
Vol.16 No.11,
November
18,
2026
ABSTRACT: Background: Partial-thickness rotator cuff tears (PTRCTs) may progress despite symptomatic improvement. Human-derived collagen has been proposed as a biologic augmentation strategy to promote tendon remodeling; however, evidence for direct intratendinous application in PTRCTs remains limited. This study compared clinical and structural outcomes of arthroscopic acromioplasty with intratendinous human-derived collagen injection versus acromioplasty alone in articular-sided PTRCTs. Methods: This retrospective comparative study included 60 patients with symptomatic articular-sided PTRCTs involving less than 50% of tendon thickness: 30 underwent acromioplasty with intratendinous human-derived collagen injection (Group 1) and 30 underwent acromioplasty alone (Group 2). Clinical outcomes were assessed using the visual analog scale (VAS) and American Shoulder and Elbow Surgeons (ASES) score. Structural changes were evaluated using 3.0-T magnetic resonance imaging (MRI) at 6 months and categorized as decreased (>2-mm reduction), unchanged (≤2-mm change), or increased (>2-mm enlargement). Postoperative clinical outcomes were compared using analysis of covariance adjusted for baseline scores. Results: Both groups improved significantly in VAS and ASES scores at 6 months (all p p = 0.597 and p = 0.432, respectively). The overall distribution of MRI changes showed a borderline, nonsignificant difference (p = 0.051), whereas a post hoc exploratory dichotomous analysis found a higher frequency of >2-mm tear-size reduction in Group 1 than in Group 2 (36.7% vs. 10.0%; unadjusted p = 0.030; odds ratio, 5.21; 95% confidence interval, 1.28 - 21.24). Conclusions: No additional short-term clinical benefit of collagen injection was detected in pain or function compared with acromioplasty alone. An exploratory post hoc analysis showed a higher proportion of >2-mm tear-size reduction on MRI (unadjusted p = 0.030); this hypothesis-generating finding requires prospective confirmation. Larger prospective studies with longer follow-up are required.